rs373124557
Variant summary
Our verdict is Likely benign. Variant got -5 ACMG points: 1P and 6B. PP2BP4_ModerateBS2
The NM_000719.7(CACNA1C):c.3679G>A(p.Val1227Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000415 in 1,614,084 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/19 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Consequence
NM_000719.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -5 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CACNA1C | NM_000719.7 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | ENST00000399655.6 | NP_000710.5 | |
CACNA1C | NM_001167623.2 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | ENST00000399603.6 | NP_001161095.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CACNA1C | ENST00000399603.6 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 5 | NM_001167623.2 | ENSP00000382512.1 | ||
CACNA1C | ENST00000399655.6 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | NM_000719.7 | ENSP00000382563.1 | ||
CACNA1C | ENST00000682544.1 | c.3829G>A | p.Val1277Ile | missense_variant | Exon 29 of 50 | ENSP00000507184.1 | ||||
CACNA1C | ENST00000406454.8 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 48 | 5 | ENSP00000385896.3 | |||
CACNA1C | ENST00000399634.6 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 5 | ENSP00000382542.2 | |||
CACNA1C | ENST00000683824.1 | c.3844G>A | p.Val1282Ile | missense_variant | Exon 29 of 48 | ENSP00000507867.1 | ||||
CACNA1C | ENST00000347598.9 | c.3739G>A | p.Val1247Ile | missense_variant | Exon 29 of 49 | 1 | ENSP00000266376.6 | |||
CACNA1C | ENST00000344100.7 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000341092.3 | |||
CACNA1C | ENST00000327702.12 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 48 | 1 | ENSP00000329877.7 | |||
CACNA1C | ENST00000399617.6 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 48 | 5 | ENSP00000382526.1 | |||
CACNA1C | ENST00000682462.1 | c.3769G>A | p.Val1257Ile | missense_variant | Exon 28 of 47 | ENSP00000507105.1 | ||||
CACNA1C | ENST00000683781.1 | c.3769G>A | p.Val1257Ile | missense_variant | Exon 28 of 47 | ENSP00000507434.1 | ||||
CACNA1C | ENST00000683840.1 | c.3769G>A | p.Val1257Ile | missense_variant | Exon 28 of 47 | ENSP00000507612.1 | ||||
CACNA1C | ENST00000683956.1 | c.3769G>A | p.Val1257Ile | missense_variant | Exon 28 of 47 | ENSP00000506882.1 | ||||
CACNA1C | ENST00000399638.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 48 | 1 | ENSP00000382547.1 | |||
CACNA1C | ENST00000335762.10 | c.3754G>A | p.Val1252Ile | missense_variant | Exon 29 of 48 | 5 | ENSP00000336982.5 | |||
CACNA1C | ENST00000399606.5 | c.3739G>A | p.Val1247Ile | missense_variant | Exon 29 of 48 | 1 | ENSP00000382515.1 | |||
CACNA1C | ENST00000399621.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000382530.1 | |||
CACNA1C | ENST00000399637.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000382546.1 | |||
CACNA1C | ENST00000402845.7 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000385724.3 | |||
CACNA1C | ENST00000399629.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000382537.1 | |||
CACNA1C | ENST00000682336.1 | c.3754G>A | p.Val1252Ile | missense_variant | Exon 29 of 47 | ENSP00000507898.1 | ||||
CACNA1C | ENST00000399591.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 46 | 1 | ENSP00000382500.1 | |||
CACNA1C | ENST00000399595.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 46 | 1 | ENSP00000382504.1 | |||
CACNA1C | ENST00000399649.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 46 | 1 | ENSP00000382557.1 | |||
CACNA1C | ENST00000399597.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000382506.1 | |||
CACNA1C | ENST00000399601.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000382510.1 | |||
CACNA1C | ENST00000399641.6 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000382549.1 | |||
CACNA1C | ENST00000399644.5 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | 1 | ENSP00000382552.1 | |||
CACNA1C | ENST00000682835.1 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 47 | ENSP00000507282.1 | ||||
CACNA1C | ENST00000683482.1 | c.3670G>A | p.Val1224Ile | missense_variant | Exon 28 of 47 | ENSP00000507169.1 | ||||
CACNA1C | ENST00000682686.1 | c.3679G>A | p.Val1227Ile | missense_variant | Exon 28 of 46 | ENSP00000507309.1 | ||||
CACNA1C | ENST00000480911.6 | n.*2286G>A | non_coding_transcript_exon_variant | Exon 26 of 27 | 5 | ENSP00000437936.2 | ||||
CACNA1C | ENST00000480911.6 | n.*2286G>A | 3_prime_UTR_variant | Exon 26 of 27 | 5 | ENSP00000437936.2 |
Frequencies
GnomAD3 genomes AF: 0.0000591 AC: 9AN: 152198Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000359 AC: 9AN: 250764Hom.: 0 AF XY: 0.0000442 AC XY: 6AN XY: 135740
GnomAD4 exome AF: 0.0000397 AC: 58AN: 1461886Hom.: 1 Cov.: 31 AF XY: 0.0000413 AC XY: 30AN XY: 727246
GnomAD4 genome AF: 0.0000591 AC: 9AN: 152198Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74364
ClinVar
Submissions by phenotype
not provided Uncertain:4
- -
- -
In silico analysis, which includes protein predictors and evolutionary conservation, supports that this variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge -
The CACNA1C c.3679G>A; p.Val1227Ile variant (rs373124557), to our knowledge, is not reported in the medical literature but is reported in ClinVar (Variation ID: 234984). This variant is found in the general population with an overall allele frequency of 0.0035% (10/282176 alleles) in the Genome Aggregation Database. Computational analyses are uncertain whether this variant is neutral or deleterious (REVEL: 0.283). Due to limited information, the clinical significance of this variant is uncertain at this time. -
not specified Uncertain:1
Note this variant was found in clinical genetic testing performed by one or more labs who may also submit to ClinVar. Thus any internal case data may overlap with the internal case data of other labs. The interpretation reviewed below is that of the Stanford Center for Inherited Cardiovascular Disease. Based on the data reviewed we consider this a variant of uncertain significance. This is a novel variant. It is not reported in dbSNP as a benign polymorphism nor is it reported in published literature in association with disease. This is a conservative amino acid change with a nonpolar Valine replaced by a nonpolar Leucine. Valine is not conserved at this position across species and there are no reported disease associated variants at nearby codons (Google, Gene Connection for the Heart Database, Mutadatabase). In silico analysis (PolyPhen) predicts the amino acid change to be benign. The reporting lab did not find this variant in 600 presumably healthy controls consisting of both Caucasian and African American ancestry. -
Timothy syndrome;C2678478:Brugada syndrome 3;CN260585:Long qt syndrome 8 Uncertain:1
- -
Short QT Syndrome 4 Uncertain:1
- -
Timothy syndrome Uncertain:1
The observed variant c.3679G>A (p.V1227I) is not reported in 1000 Genomes and has minor allele frequency of 0.00002479 in ExAC database. The in silico prediction of the variant is benign by MutationTaster2 and tolerated by SIFT. -
Timothy syndrome;na:arrhythmogenic disorders Uncertain:1
The p.Val1227Ile variant in the CACNA1C gene has not been previously reported in association with disease. This variant has also been identified in 8/129006 European (non-Finnish) chromosomes (10/282176 chromosomes overall) by the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This variant is present in ClinVar (Variation ID: 234984). The CACNA1C gene has fewer missense variants in the general population than expected. A low rate of missense variation may suggest that this gene is intolerant to missense variation. Computational tools predict that this variant is neither deleterious nor benign; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, the significance of the p.Val1227Ile variant is uncertain. Additional information is needed to resolve the significance of this variant. [ACMG evidence codes used: PM2; PP2] -
Timothy syndrome;na:QT prolongation and arrhythmias in the absence of other syndromic features;na:arrhythmogenic disorders;na:short QT interval with or without a Brugada syndrome ECG pattern Uncertain:1
The p.Val1227Ile variant in the CACNA1C gene has not been previously reported in association with disease. This variant has also been identified in 8/129006 European (non-Finnish) chromosomes (10/282176 chromosomes overall) by the Genome Aggregation Database (http://gnomad.broadinstitute.org/). This variant is present in ClinVar (Variation ID: 234984). The CACNA1C gene has fewer missense variants in the general population than expected. A low rate of missense variation may suggest that this gene is intolerant to missense variation. Computational tools predict that this variant is neither deleterious nor benign; however, the accuracy of in silico algorithms is limited. These data were assessed using the ACMG/AMP variant interpretation guidelines. In summary, the significance of the p.Val1227Ile variant is uncertain. Additional information is needed to resolve the significance of this variant. [ACMG evidence codes used: PM2; PP2] -
Long QT syndrome Uncertain:1
This sequence change replaces valine, which is neutral and non-polar, with isoleucine, which is neutral and non-polar, at codon 1227 of the CACNA1C protein (p.Val1227Ile). This variant is present in population databases (rs373124557, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with CACNA1C-related conditions. ClinVar contains an entry for this variant (Variation ID: 234984). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is not expected to disrupt CACNA1C protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Cardiovascular phenotype Benign:1
This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at